Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Arnaud Comte

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Scientific Reports|March 25, 2022
Nigratine as dual inhibitor of necroptosis and ferroptosis regulated cell deathClaire Delehouzé, Arnaud Comte, Stephen Adonai Leon-Icaza, et al.
Antibiotics (Basel, Switzerland)|October 27, 2022
An Optimized Workflow for the Discovery of New Antimicrobial Compounds Targeting Bacterial RNA Polymerase Complex FormationAlessia Caputo, Sara Sartini, Elisabetta Levati, et al.
The FEBS Journal|July 18, 2017
Sibiriline, a new small chemical inhibitor of receptor-interacting protein kinase 1, prevents immune-dependent hepatitisFabienne Le Cann, Claire Delehouzé, Sabrina Leverrier-Penna, et al.
Nature Communications|May 26, 2018
Targeting RNA structure in SMN2 reverses spinal muscular atrophy molecular phenotypesAmparo Garcia-Lopez, Francesca Tessaro, Hendrik R A Jonker, et al.
Cell Death Discovery|November 28, 2025
Sibiriline, a novel dual inhibitor of necroptosis and ferroptosis, prevents RIPK1 kinase activity and (phospho)lipid peroxidation as a potential therapeutic strategyClaire Delehouzé, Melodie Mallais, Arnaud Comte, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Scientific Reports|March 25, 2022
Nigratine as dual inhibitor of necroptosis and ferroptosis regulated cell deathClaire Delehouzé, Arnaud Comte, Stephen Adonai Leon-Icaza, et al.
Antibiotics (Basel, Switzerland)|October 27, 2022
An Optimized Workflow for the Discovery of New Antimicrobial Compounds Targeting Bacterial RNA Polymerase Complex FormationAlessia Caputo, Sara Sartini, Elisabetta Levati, et al.
The FEBS Journal|July 18, 2017
Sibiriline, a new small chemical inhibitor of receptor-interacting protein kinase 1, prevents immune-dependent hepatitisFabienne Le Cann, Claire Delehouzé, Sabrina Leverrier-Penna, et al.
Nature Communications|May 26, 2018
Targeting RNA structure in SMN2 reverses spinal muscular atrophy molecular phenotypesAmparo Garcia-Lopez, Francesca Tessaro, Hendrik R A Jonker, et al.
Cell Death Discovery|November 28, 2025
Sibiriline, a novel dual inhibitor of necroptosis and ferroptosis, prevents RIPK1 kinase activity and (phospho)lipid peroxidation as a potential therapeutic strategyClaire Delehouzé, Melodie Mallais, Arnaud Comte, et al.
Pageof 2